AFFLUENT FDN (01757) has announced that, in response to rising consumer spending and an aging population in China, the Group will actively align with national policies and plans to launch new business operations in the country. The focus will be on two major chain industries: (i) medical aesthetics, and (ii) health and wellness. In the medical aesthetics sector, the Group intends to concentrate on developing related services, including integrating top-tier medical expert teams nationwide, establishing high-end medical aesthetic hospitals, and forming partnerships with regenerative medicine institutions. The Group aims to build a comprehensive and professional medical aesthetics ecosystem. In the health and wellness sector, the Group plans to develop its footprint in the wellness industry. Proposed initiatives include establishing a nationwide network of wellness chain stores, leveraging the advantages of clustered outlets, and strengthening the entire industry chain to create a closed-loop ecosystem. The Group will actively explore vertical extension and horizontal collaboration across the industry chain. Through strategic investments, business cooperation, and mergers and acquisitions, the Group intends to connect with more partners and resources in both the medical aesthetics and wellness sectors, aiming to build an open, collaborative, and mutually beneficial industrial ecosystem platform. This strategy is designed to cultivate new growth drivers for the two chain industries. The Board believes that the new ventures will create long-term value for the Company's shareholders and strengthen the Group's strategic positioning in China.